KIT and ovarian carcinoma: Besides, Fang C et al.44 found that the c-Kit/PHB axis enhances ovarian cancer stemness, tumorigenicity, and chemotherapy resistance by promoting PHB phosphorylation and stabilizing Notch3 and β-catenin signaling pathways, suggesting it as a potential therapeutic target.